In June of 2021 the Alzheimer’s drug, Aduhelm, was approved by the U.S. Food and Drug Administration (FDA). Aduhelm is a monoclonal antibody. It targets a specific protein in the brain that is thought to form plaques in the brains of Alzheimer’s patients, causing brain cells to atrophy and die.
Category: Consumer-Driven Health Care
Wednesday Links
- Less developed countries discover how to provide economical mental health care: use non-specialists.
- How reliable are patient online reviews at detecting physician and hospital quality? Not good.
- Is Obamacare’s free preventive medicine mandate unconstitutional? (WSJ)
- 94% of US residents have gotten Covid.
NYT: It’s Not Your Fault You’re Fat
According to the Center for Disease Control and Prevention (CDC) the prevalence of obesity among adults in the U.S. is about 42%, rising more than 10 percentage points in the past two decades. During that same period, severe obesity about doubled, to 9.2%. It is estimated that medical costs attributed to obesity are $173 billion, or about $1,861 higher per obese individual compared to adults with a healthy weight.
Pharmacist: That Prescription Will Cost You $3.5 Million!
A new record has been set for the highest price medication. The newly approved hemophilia drug Hemgenix.